(SMWB) SimilarWeb - Overview
Sector: Technology | Industry: Software - Application | Exchange: NYSE (USA) | Market Cap: 362m USD | Total Return: -44% in 12m
Avg Turnover: 2.71M
Qual. Beats: 0
Rev. Trend: 99.8%
Qual. Beats: 0
Warnings
Interest Coverage Ratio -1.9 is critical
Altman Z'' -9.02 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Similarweb Ltd. (SMWB) is an Israeli-based software company specializing in digital market intelligence and data analytics. The firm provides a proprietary platform that tracks website and mobile app traffic, enabling businesses to benchmark performance, analyze competitor acquisition strategies, and monitor consumer behavior across various digital channels.
The company operates within the Application Software sub-industry, utilizing a Software-as-a-Service (SaaS) business model to serve diverse sectors including retail, finance, and institutional investing. This sector is characterized by high recurring revenue potential and the increasing corporate demand for alternative data to inform strategic decision-making.
The product suite includes specialized modules for sales intelligence, retail optimization, and stock market analysis, alongside data-as-a-service and advisory offerings. Investors should review the detailed fundamental metrics available on ValueRay to better understand the companys financial health.
Headquartered in Givatayim, Similarweb facilitates data-driven due diligence and market forecasting for a global client base, supporting critical business operations from lead generation to investment ideation.
- Enterprise customer retention and upsell drive recurring revenue growth
- AI-driven data demand accelerates digital intelligence platform adoption
- Operating leverage improvements lead to sustained positive free cash flow
- Competitive pressure from alternative data providers impacts market share margins
| Net Income: -30.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -5.93 > 1.0 |
| NWC/Revenue: -22.50% < 20% (prev -18.57%; Δ -3.94% < -1%) |
| CFO/TA 0.04 > 3% & CFO 10.0m > Net Income -30.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.3m) vs 12m ago 4.98% < -2% |
| Gross Margin: 79.43% > 18% (prev 0.78%; Δ 7.86k% > 0.5%) |
| Asset Turnover: 117.0% > 50% (prev 108.6%; Δ 8.43% > 0%) |
| Interest Coverage Ratio: -1.88 > 6 (EBITDA TTM -7.54m / Interest Expense TTM 8.78m) |
| A: -0.25 (Total Current Assets 128.1m - Total Current Liabilities 193.2m) / Total Assets 257.1m |
| B: -1.57 (Retained Earnings -403.9m / Total Assets 257.1m) |
| C: -0.07 (EBIT TTM -16.5m / Avg Total Assets 247.4m) |
| D: -1.71 (Book Value of Equity -403.5m / Total Liabilities 236.2m) |
| Altman-Z'' = -9.02 = D |
| DSRI: 1.08 (Receivables 48.6m/40.0m, Revenue 289.4m/258.0m) |
| GMI: 0.99 (GM 79.43% / 78.27%) |
| AQI: 1.38 (AQ_t 0.29 / AQ_t-1 0.21) |
| SGI: 1.12 (Revenue 289.4m / 258.0m) |
| TATA: -0.16 (NI -30.0m - CFO 10.0m) / TA 257.1m) |
| Beneish M = -2.82 (Cap -4..+1) = A |
As of May 30, 2026, the stock is trading at USD 4.15 with a total of 888,208 shares traded.
Over the past week, the price has changed by +9.79%,
over one month by +53.14%,
over three months by +60.23% and
over the past year by -43.99%.
SimilarWeb has received a consensus analysts rating of 4.56. Therefore, it is recommended to buy SMWB.
- StrongBuy: 5
- Buy: 4
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 4.2 | 0.5% |
P/E Forward = 29.4985
P/S = 1.2802
P/B = 17.3729
Revenue TTM = 289.4m USD
EBIT TTM = -16.5m USD
EBITDA TTM = -7.54m USD
Long Term Debt = 33.0m USD (estimated: total debt 39.4m - short term 6.41m)
Short Term Debt = 6.41m USD (from shortTermDebt, last quarter)
Debt = 39.4m USD (from shortLongTermDebtTotal, last quarter) (leases 39.4m already included)
Net Debt = -32.3m USD (calculated: Debt 39.4m - CCE 71.7m)
Enterprise Value = 329.5m USD (361.8m + Debt 39.4m - CCE 71.7m)
Interest Coverage Ratio = -1.88 (Ebit TTM -16.5m / Interest Expense TTM 8.78m)
EV/FCF = 37.88x (Enterprise Value 329.5m / FCF TTM 8.70m)
FCF Yield = 2.64% (FCF TTM 8.70m / Enterprise Value 329.5m)
FCF Margin = 3.01% (FCF TTM 8.70m / Revenue TTM 289.4m)
Net Margin = -10.38% (Net Income TTM -30.0m / Revenue TTM 289.4m)
Gross Margin = 79.43% ((Revenue TTM 289.4m - Cost of Revenue TTM 59.5m) / Revenue TTM)
Gross Margin QoQ = 78.83% (prev 79.35%)
Tobins Q-Ratio = 1.28 (Enterprise Value 329.5m / Total Assets 257.1m)
Interest Expense / Debt = 22.30% (Interest Expense 8.78m / Debt 39.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -13.0m (EBIT -16.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.66 (Total Current Assets 128.1m / Total Current Liabilities 193.2m)
Debt / Equity = 1.89 (Debt 39.4m / totalStockholderEquity, last quarter 20.8m)
Debt / EBITDA = 4.29 (negative EBITDA) (Net Debt -32.3m / EBITDA -7.54m)
Debt / FCF = -3.71 (Net Debt -32.3m / FCF TTM 8.70m)
Total Stockholder Equity = 23.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -12.14% (Net Income -30.0m / Total Assets 257.1m)
RoE = -7.03% (Net Income TTM -30.0m / Total Stockholder Equity 427.0m)
RoCE = -3.59% (EBIT -16.5m / Capital Employed (Equity 427.0m + L.T.Debt 33.0m))
RoIC = -18.55% (negative operating profit) (NOPAT -13.0m / Invested Capital 70.3m)
WACC = 10.05% (E(361.8m)/V(401.2m) * Re(9.23%) + D(39.4m)/V(401.2m) * Rd(22.30%) * (1-Tc(0.21)))
Discount Rate = 9.23% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 100.00 | Cagr: 4.86%
[DCF] Terminal Value 67.01% ; FCFF base≈14.1m ; Y1≈12.3m ; Y5≈9.97m
[DCF] Fair Price = 1.80 (EV 125.0m - Net Debt -32.3m = Equity 157.3m / Shares 87.6m; r=10.05% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.45 | # QB: 0
Revenue Correlation: 99.80 | Revenue CAGR: 13.58% | SUE: 0.47 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.03 | Chg30d=-27.84% | Revisions=-60% | Analysts=8
EPS next Quarter (2026-09-30): EPS=0.05 | Chg30d=-20.63% | Revisions=-20% | Analysts=8
EPS current Year (2026-12-31): EPS=0.15 | Chg30d=-24.65% | Revisions=-64% | GrowthEPS=+154.6% | GrowthRev=+9.4%
EPS next Year (2027-12-31): EPS=0.24 | Chg30d=-0.29% | Revisions=-14% | GrowthEPS=+59.3% | GrowthRev=+8.8%
[Analyst] Revisions Ratio: -64%